Download PDF
J Knee Surg 2016; 29(07): 555-563
DOI: 10.1055/s-0035-1568988
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Subchondroplasty for Treating Bone Marrow Lesions

Steven Brad Cohen
1   Department of Orthopedic Surgery, Rothman Institute, Thomas Jefferson University, Philadelphia, Pennsylvania
,
Peter F. Sharkey
1   Department of Orthopedic Surgery, Rothman Institute, Thomas Jefferson University, Philadelphia, Pennsylvania
› Author Affiliations
Further Information

Publication History

03 August 2015

10 October 2015

Publication Date:
07 December 2015 (online)

   Permissions and Reprints

Abstract

The prognosis of osteoarthritis (OA) is worsened by persistent subchondral defects known as bone marrow lesions (BMLs), which herald severe joint degeneration and the need for joint replacement. Joint-preserving treatments that reverse the progression of pain and immobility are limited. Subchondroplasty is a procedure developed to treat BMLs by injecting a calcium phosphate bone substitute into compromised subchondral bone, under fluoroscopic guidance. Here we evaluate the effectiveness of this approach for relieving pain and improving function in patients with documented BMLs and advanced knee OA, in a retrospective study. Data were collected from a consecutive patient series (n = 66) who underwent subchondroplasty combined with arthroscopy, performed at a single center by one surgeon. We observed significant improvements in both pain and function following subchondroplasty with arthroscopic debridement, as measured by the visual analog scale (VAS) and the International Knee Documentation Committee (IKDC) Subjective Knee Evaluation Form, through 2 years postoperative follow-up. Given that arthroscopic debridement alone has been previously shown to yield insignificant pain relief beyond 6 months postoperatively, our results suggest that subchondroplasty may be a promising approach for the treatment of OA with BMLs.

Keywords

arthritis - arthroscopy - bone marrow edema - bone marrow lesion - subchondroplasty
 

  • References

  • 1 Eriksen EF, Ringe JD. Bone marrow lesions: a universal bone response to injury?. Rheumatol Int 2012; 32 (3) 575-584
    CrossrefPubMedSearch in Google Scholar
  • 2 Radke S, Kirschner S, Seipel V, Rader C, Eulert J. Treatment of transient bone marrow oedema of the hip—a comparative study. Int Orthop 2003; 27 (3) 149-152
    PubMedSearch in Google Scholar
  • 3 Hofmann S, Engel A, Neuhold A, Leder K, Kramer J, Plenk Jr H. Bone-marrow oedema syndrome and transient osteoporosis of the hip. an MRI-controlled study of treatment by core decompression. J Bone Joint Surg Br 1993; 75 (2) 210-216
    PubMedSearch in Google Scholar
  • 4 Shubin Stein BE, Ahmad CS, Pfaff CH, Bigliani LU, Levine WN. A comparison of magnetic resonance imaging findings of the acromioclavicular joint in symptomatic versus asymptomatic patients. J Shoulder Elbow Surg 2006; 15 (1) 56-59
    CrossrefPubMedSearch in Google Scholar
  • 5 Orr JD, Sabesan V, Major N, Nunley J. Painful bone marrow edema syndrome of the foot and ankle. Foot Ankle Int 2010; 31 (11) 949-953
    CrossrefPubMedSearch in Google Scholar
  • 6 Cohen SB, Sharkey PF. Surgical treatment of osteoarthritis pain related to subchondral bone defects or bone marrow lesions: subchondroplasty. Tech Knee Surg 2012; 11 (4) 170-175
    CrossrefPubMedSearch in Google Scholar
  • 7 Jimenez-Boj E, Nöbauer-Huhmann I, Hanslik-Schnabel B , et al. Bone erosions and bone marrow edema as defined by magnetic resonance imaging reflect true bone marrow inflammation in rheumatoid arthritis. Arthritis Rheum 2007; 56 (4) 1118-1124
    CrossrefPubMedSearch in Google Scholar
  • 8 Roemer FW, Neogi T, Nevitt MC , et al. Subchondral bone marrow lesions are highly associated with, and predict subchondral bone attrition longitudinally: the MOST study. Osteoarthritis Cartilage 2010; 18 (1) 47-53
    CrossrefPubMedSearch in Google Scholar
  • 9 Farr II J, Cohen SB. Expanding applications of the subchondroplasty procedure for the treatment of bone marrow lesions observed on magnetic resonance imaging. Oper Tech Sports Med 2013; 21 (2) 138-143
    CrossrefPubMedSearch in Google Scholar
  • 10 Tanamas SK, Wluka AE, Pelletier JP , et al. Bone marrow lesions in people with knee osteoarthritis predict progression of disease and joint replacement: a longitudinal study. Rheumatology (Oxford) 2010; 49 (12) 2413-2419
    CrossrefPubMedSearch in Google Scholar
  • 11 Wluka AE, Wang Y, Davies-Tuck M, English DR, Giles GG, Cicuttini FM. Bone marrow lesions predict progression of cartilage defects and loss of cartilage volume in healthy middle-aged adults without knee pain over 2 yrs. Rheumatology (Oxford) 2008; 47 (9) 1392-1396
    CrossrefPubMedSearch in Google Scholar
  • 12 Felson DT, Chaisson CE, Hill CL , et al. The association of bone marrow lesions with pain in knee osteoarthritis. Ann Intern Med 2001; 134 (7) 541-549
    CrossrefPubMedSearch in Google Scholar
  • 13 Taljanovic MS, Graham AR, Benjamin JB , et al. Bone marrow edema pattern in advanced hip osteoarthritis: quantitative assessment with magnetic resonance imaging and correlation with clinical examination, radiographic findings, and histopathology. Skeletal Radiol 2008; 37 (5) 423-431
    CrossrefPubMedSearch in Google Scholar
  • 14 Moseley JB, O'Malley K, Petersen NJ , et al. A controlled trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med 2002; 347 (2) 81-88
    Search in Google Scholar
  • 15 Kirkley A, Birmingham TB, Litchfield RB , et al. A randomized trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med 2008; 359 (11) 1097-1107
    CrossrefPubMedSearch in Google Scholar
  • 16 Thorlund JB, Juhl CB, Roos EM, Lohmander LS. Arthroscopic surgery for degenerative knee: systematic review and meta-analysis of benefits and harms. BMJ 2015; 350: h2747
    CrossrefPubMedSearch in Google Scholar
  • 17 Scher C, Craig J, Nelson F. Bone marrow edema in the knee in osteoarthrosis and association with total knee arthroplasty within a three-year follow-up. Skeletal Radiol 2008; 37 (7) 609-617
    CrossrefPubMedSearch in Google Scholar
  • 18 Kröner AH, Berger CE, Kluger R, Oberhauser G, Bock P, Engel A. Influence of high tibial osteotomy on bone marrow edema in the knee. Clin Orthop Relat Res 2007; 454 (454) 155-162
    CrossrefPubMedSearch in Google Scholar
  • 19 Healy WL, Della Valle CJ, Iorio R , et al. Complications of total knee arthroplasty: standardized list and definitions of the Knee Society. Clin Orthop Relat Res 2013; 471 (1) 215-220
    CrossrefPubMedSearch in Google Scholar
  • 20 Kurtz S, Mowat F, Ong K, Chan N, Lau E, Halpern M. Prevalence of primary and revision total hip and knee arthroplasty in the United States from 1990 through 2002. J Bone Joint Surg Am 2005; 87 (7) 1487-1497
    CrossrefPubMedSearch in Google Scholar
  • 21 Kurtz SM, Lau E, Ong K, Zhao K, Kelly M, Bozic KJ. Future young patient demand for primary and revision joint replacement: national projections from 2010 to 2030. Clin Orthop Relat Res 2009; 467 (10) 2606-2612
    CrossrefPubMedSearch in Google Scholar
  • 22 Franklin PD, Li W, Ayers DC. The Chitranjan Ranawat Award: functional outcome after total knee replacement varies with patient attributes. Clin Orthop Relat Res 2008; 466 (11) 2597-2604
    CrossrefPubMedSearch in Google Scholar
  • 23 Mizner RL, Petterson SC, Clements KE, Zeni Jr JA, Irrgang JJ, Snyder-Mackler L. Measuring functional improvement after total knee arthroplasty requires both performance-based and patient-report assessments: a longitudinal analysis of outcomes. J Arthroplasty 2011; 26 (5) 728-737
    CrossrefPubMedSearch in Google Scholar
  • 24 Browne JP, Bastaki H, Dawson J. What is the optimal time point to assess patient-reported recovery after hip and knee replacement? A systematic review and analysis of routinely reported outcome data from the English patient-reported outcome measures programme. Health Qual Life Outcomes 2013; 11: 128
    CrossrefPubMedSearch in Google Scholar
  • 25 Singh JA, O'Byrne M, Harmsen S, Lewallen D. Predictors of moderate-severe functional limitation after primary total knee arthroplasty (TKA): 4701 TKAs at 2 years and 2935 TKAs at 5 years. Osteoarthritis Cartilage 2010; 18 (4) 515-521
    CrossrefPubMedSearch in Google Scholar
  • 26 Mastbergen SC, Lafeber FP. Changes in subchondral bone early in the development of osteoarthritis. Arthritis Rheum 2011; 63 (9) 2561-2563
    CrossrefPubMedSearch in Google Scholar
  • 27 Lim YZ, Wang Y, Wluka AE , et al. Association of obesity and systemic factors with bone marrow lesions at the knee: a systematic review. Semin Arthritis Rheum 2014; 43 (5) 600-612
    CrossrefPubMedSearch in Google Scholar
  • 28 Moore WR, Graves SE, Bain GI. Synthetic bone graft substitutes. ANZ J Surg 2001; 71 (6) 354-361
    CrossrefPubMedSearch in Google Scholar
  • 29 Tofighi A, Rosenberg A, Sutaria M, Balata S, Chang J. New generation of synthetic, bioresorbable and injectable calcium phosphate bone substitute materials: Alpha-bsm®, Beta-bsmTM and Gamma-bsmTM. J Biomimet Biomat Tissue Engineer 2009; 2: 39-55
    PubMedSearch in Google Scholar
  • 30 Sharkey PF, Cohen SB, Leinberry CF, Parvizi J. Subchondral bone marrow lesions associated with knee osteoarthritis. Am J Orthop 2012; 41 (9) 413-417
    PubMedSearch in Google Scholar
  • 31 Bajammal SS, Zlowodzki M, Lelwica A , et al. The use of calcium phosphate bone cement in fracture treatment. A meta-analysis of randomized trials. J Bone Joint Surg Am 2008; 90 (6) 1186-1196
    CrossrefPubMedSearch in Google Scholar
  • 32 Higgins LD, Taylor MK, Park D , et al; International Knee Documentation Committee. Reliability and validity of the International Knee Documentation Committee (IKDC) Subjective Knee Form. Joint Bone Spine 2007; 74 (6) 594-599
    Search in Google Scholar
  • 33 Browne JE, Branch TP. Surgical alternatives for treatment of articular cartilage lesions. J Am Acad Orthop Surg 2000; 8 (3) 180-189
    PubMedSearch in Google Scholar
  • 34 Tubach F, Ravaud P, Baron G , et al. Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement. Ann Rheum Dis 2005; 64 (1) 29-33
    CrossrefPubMedSearch in Google Scholar
  • 35 Irrgang JJ, Anderson AF, Boland AL , et al; International Knee Documentation Committee. Responsiveness of the International Knee Documentation Committee Subjective Knee Form. Am J Sports Med 2006; 34 (10) 1567-1573
    CrossrefPubMedSearch in Google Scholar
  • 36 Grilo RM, Treves R, Preux PM, Vergne-Salle P, Bertin P. Clinically relevant VAS pain score change in patients with acute rheumatic conditions. Joint Bone Spine 2007; 74 (4) 358-361
    CrossrefPubMedSearch in Google Scholar
  • 37 Chatterjee D, McGee A, Strauss E, Youm T, Jazrawi L. Subchondral calcium phosphate is ineffective for bone marrow edema lesions in adults with advanced osteoarthritis. Clin Orthop Relat Res 2015; 473 (7) 2334-2342
    CrossrefPubMedSearch in Google Scholar
  • 38 Mitsou A, Vallianatos P, Piskopakis N, Maheras S. Anterior cruciate ligament reconstruction by over-the-top repair combined with popliteus tendon plasty. J Bone Joint Surg Br 1990; 72 (3) 398-404
    PubMedSearch in Google Scholar
  • 39 Bengtsson J, Möllborg J, Werner S. A study for testing the sensitivity and reliability of the Lysholm knee scoring scale. Knee Surg Sports Traumatol Arthrosc 1996; 4 (1) 27-31
    CrossrefPubMedSearch in Google Scholar
  • 40 U.S. Agency for Healthcare Research and Quality. National and regional estimates on hospital use for all patients from the HCUP Nationwide Inpatient Sample (NIS) for arthroplasty of knee (surgical reconstruction or replacement of knee). 2012. http://hcupnet.ahrq.gov/HCUPnet.jsp
    PubMed